Chapter 39- Attention- Deficit Hyperactivity

Description

IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Explain the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision criteria necessary for the diagnosis of attention-deficit hyperactivity disorder.
2. Recommend a therapeutic plan, including initial doses, dosage forms, and monitoring parameters, for a patient with attention-deficit hyperactivity disorder.
3. Differentiate between the available pharmacotherapy used for attention-deficit hyperactivity disorder with respect to pharmacology and pharmaceutical formulation.
4. Recommend second-line and/or adjunctive agents that can be effective alternatives in the treatment of attention-deficit hyperactivity disorder when stimulant therapy is less than adequate.
5. Address potential cost-benefit issues associated with pharmacotherapy of attention-deficit hyperactivity disorder.
6. Recommend strategies for minimizing adverse effects of attention-deficit hyperactivity disorder medications.

Courses Offered